BlueWind Medical, a medical device company developing minimally invasive neurostimulation devices and with a main office in Park City, has appointed Kerry Nelson to its board of directors. Nelson is a medical device investor and fund manager who has launched and managed healthcare focused investment funds. She is portfolio manager and founder of Skystone Capital Management LP, which has been solely focused on the healthcare industry since a spin out from JP Morgan Chase & Co. Previously, she was a portfolio manager with Highbridge Capital Management, spent four years as a partner with Blum Capital Partners LP, and served as a portfolio manager and analyst at Fidelity. She previously served as a board observer at Haemonetics and Kinetics Concepts Inc.